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Introduction
As in most other Western countries,
street drug use – dominated by an esti-
mated population of 100,000 injection
drug users (IDUs) (Federal/Provin-
cial/Territorial Committee on Injec-
tion Drug Use, 2001; Remis et al.,
1998) – is associated with considerable
harms in Canada. These include ap-
proximately 1,000 overdose deaths per
year, a high proportion of HCV and
HIV infections, and a substantive so-
cial cost burden (primarily crime-relat-
ed) associated with street drug use
(Fischer, Rehm, & Blitz-Miller, 2000b;
Fischer et al., 2005a; CCENDU, 2003;
Wall et al. 2001).
Although the evolution of street
drug use in Canada is strongly associat-
ed with injection heroin use, it is evi-
dent that current street drug users are
increasingly characterized by diverse
forms of both poly- and non-injection
Zusammenfassung
Fragestellung: Es wurden Unter-
schiede zwischen Ko-Gebrauchern
von Kokain und Crack in einer kana-
dischen Kohorte illegaler Opioid-
Konsumenten (»OPICAN«) unter-
sucht. Methodik: Kohortenteilneh-
mer wurden durch Schneeball-Me-
thoden rekrutiert und mittels eines
standardisierten Instrumenten-Pro-
tokolls befragt. Prävalenzraten ver-
schiedener Substanzen sowie Un-
terschiede zwischen ausgewählten
Indikatoren und den beiden Sub-
gruppen wurden bivariat geprüft.
Ergebnisse: Zirka die Hälfte der
Studienteilnehmer indizierten Ko-
Konsum von Crack beziehungswei-
se Kokain. Erstere Gruppe zeichne-
te sich primär durch sozioökono-
mische Marginalisierung, zweitere
durch eine höhere Prävalenz von
Depression aus. Schlussfolgerun-
gen: Ko-Gebraucher von Opioiden
mit Kokain und Crack in Kanada
können als distinkte Subkulturen
mit spezifischen Risikofaktoren an-
gesehen werden. Ausgewählte Im-
plikationen für Interventionen wer-
den angesprochen.
Abstract
Objectives: Differences between co-
caine and crack co-users at baseline in
a cohort of illicit opioid users in five
Canadian cities (»OPICAN«) were
explored. Methods: Cohort subjects
were recruited by snowball methods,
and assessed through a standardised
protocol. Drug-use prevalence rates
and bivariate correlations between se-
lected indicators and the two sub-
groups were assessed. Results: Co-
caine and crack co-use were prevalent
in the study cohort (55% each). Crack
co-users were primarily characterised
by socio-economic marginalization,
whereas cocaine co-users presented a
higher prevalence of depression. Con-
clusions: Canadian opioid users co-
using crack or cocaine represent dis-
tinct sub-cultures with specific risk fac-
tors. Some selective implications for
interventions are discussed.  
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substance use (Fischer et al., 2000a).
While poly-substance use profiles dif-
fer considerably across Canada, co-
caine and crack use have been shown
to play an increasing role in street drug
use populations (Leri, Bruneau, &
Stewart, 2003; Bourgois & Bruneau,
2000; Haydon & Fischer, 2005a). In
addition to mere epidemiological de-
scriptions, there is also growing evi-
dence that the co-consumption of co-
caine and/or crack is often associated
with distinct patterns of risk behaviors
or consequences (Patrick et al., 2001;
Bourgois et al., 2000; Palepu et al.,
1999). However, there are few inter-
ventions offered specifically for street
users of cocaine or crack; on the con-
trary, the co-use of these substances
often forms a barrier to accessing or
benefiting from interventions (i. e.,
treatment) (Fischer et al., 2000a). 
In this paper, we have utilized the
opportunity of an ongoing cohort of il-
licit opioid and other drug users in five
Canadian cities (»OPICAN«) to ex-
plore the characteristics of two sub-
populations of that multi-city study
population, namely those using co-
caine versus those using crack in addi-
tion to illicit opioids. The aim is to ex-
amine potential differences between
those distinct co-use populations relat-
ed to their drugs of choice, also to point
out needs for further analysis as well as
to highlight some considerations for
interventions.
Background
Cocaine and crack use in drug user
population
Several studies focussing on IDUs in
the Canadian context over the past
years have documented the high preva-
lence of both cocaine and crack use,
through various methods of adminis-
tration (Fischer et al., 2005a; Strathdee
et al., 1997a; CCENDU, 2003; Cornish
& O’Brien, 1996). The increasing co-
occurrence especially of opioid use,
and cocaine or crack use, in street drug
user populations needs to be under-
stood in consideration of the fact that
those two drug categories feature unique
– and desirable – interactive pharma-
cological effects, likely fuelling their in-
creasingly prevalent use in various
combinations (Leri et al., 2003). For
example, cocaine was already the main
drug injected among two thirds of the
Vancouver IDU Study (»VIDUS«) co-
hort in 1996 (Strathdee et al., 1997b).
Similarly, in the St. Luc IDU cohort in
Montreal (Leri, Stewart, Tremblay, &
Bruneau, 2004), 47% (n = 614) report-
ed the use of injected cocaine and 15%
(n = 189) reported the use of combined
heroin and cocaine by injection in the
month preceding the interview. A re-
cent study of IDUs in four Canadian
cities showed that the majority of par-
ticipants were involved in both cocaine
and crack use, although use patterns
were locally quite diverse (I-Track,
2004). Several North American treat-
ment studies have documented the
high cocaine and/or crack use involve-
ment in persons entering into opioid
substitution treatment (Grella, Anglin,
& Wugalter, 1997; Fischer, Rehm, Kim,
& Kirst, 2005; Villano, Rosenblum,
Magura, & Fong, 2002).
Risks and harms associated with
cocaine and crack use
Research evidence suggests that
street drug users involved with cocaine
or crack respectively are featuring pos-
sibly distinct risk characteristics or
harm outcomes. For example, IDUs
injecting cocaine display higher fre-
quencies of injecting than non-cocaine
injectors, often occurring in the form
of high-risk injection »binges« (Bour-
gois et al., 2000). In the VIDUS cohort,
cocaine injection has been identified
as a predictor of both HIV and HCV
prevalence (Patrick et al., 1997; Spittal
et al., 2003). Reviews of overdose mor-
tality among IDUs have identified
(combination) drug use – specifically
involving opioids and cocaine – as a
major determinant of overdose fatality
(O'Driscoll et al., 2001; Coffin et al.,
2003; Darke & Hall, 2003). During the
massive spike of fatal drug overdose in-
cidents in British Columbia in the mid-
1990s, cocaine use had been present in
a disproportionate number of over-
dose incidents (Fischer et al., 2004).
Street crack use has also been asso-
ciated with several distinct risks and
consequences (Haydon & Fischer,
2005a; Cornish et al., 1996; Hunter,
Donoghoe, & Stimson, 1995). Crack-
involved street drug users may have to
be understood more in terms of a sub-
culture in the wider sense (i. e., as de-
fined beyond mere drug use indica-
tors), distinctly defined by an extreme
degree of social marginalization that is
associated with other problem indi-
cators (Haydon, Chorny, & Fischer,
2005b). This marginalization is ex-
pressed, for example, in their high in-
volvement in sex trade activities for
income generation purposes, often in-
volving high-risk sexual behaviors 
or sex-for-crack exchanges (Inciardi,
1993; Inciardi, 1995; Inciardi & Sur-
ratt, 2001; Logan & Leukefeld., 2000;
Booth, Kwiatkowski, & Chitwood,
2000). Furthermore, crack smokers are
more likely to be inadequately housed
than non-crack drug users, and experi-
ence substantial barriers keeping them
from accessing health and social serv-
ices. Finally, crack users typically indi-
cate a much more intensive involve-
ment with crime and the criminal jus-
tice system (Johnson, Natarajan, Dun-
lap, & Elmoghazy, 1994). Grella and
colleagues (Grella, Anglin, Wugalter,
Rawson, & Hasson, 1994), in a study of
409 high risk heroin addicts in the
United States, found that criminal ac-
tivity was substantially higher in crack
than in non-crack co-users in this
population. 
There is some evidence of distinct
health risks and consequences for crack
users, for example, that they display
overall worse health status than other
drug users (Haydon et al., 2005b;
Cherubin & Sapira, 1993; Erickson,
Butters, McGillicuddy, & Hallgren,
2000; Verthein, Haasen, Prinzleve,
Degkwitz & Krausz, 2001). Several
studies have shown crack use to be an
independent predictor of HCV infec-
tion status although there is no clarity at
this point as to whether crack use (via
paraphernalia sharing) itself functions
as a causal pathway for HCV transmis-
sion, or rather is a »proxy« of other ele-
Fischer et al. | Kokain und Crack Gebrauch bei kanadischen Opioid-KonsumentenTHEMENSCHWERPUNKT
SPECIAL ISSUE
219SUCHT | 51 (4) | 217–224 | 2005
vated risk factors in this group (e.g.,
marginalization, sex work, unsafe in-
jection practices, etc) (Roy et al., 2001;
Weinstock, Bolan, Reingold, & Polish,
1993; Thorpe, Ouellet, Levy, Williams,
& Monterroso, 2000; Tortu, McMahon,
Pouget, & Hamid, 2004). Among users
in Canadian cities, crack use with un-
safe materials and paraphernalia shar-
ing is common (Haydon et al., 2005a).
Interventions
Few interventions in Canada aim
specifically at street drug users in-
volved in cocaine or crack use. The
predominant treatment approach to
street drug use is currently methadone
maintenance treatment (MMT) (Fi-
scher et al., 2000b; Strike, Urbanoski,
Fischer, Marsh & Millson, in press).
While such treatment is fairly available
in most cities, cocaine or crack use
may hinder the utilization of such
treatment. Many MMT programs con-
sider ongoing cocaine or crack use as
an indicator of the user’s non-compli-
ance with treatment, often leading to
punitive consequences (i. e., metha-
done dose reduction, removal of take-
home privileges, intensified urine-test-
ing, etc.) (Fischer et al., 2000a). Sever-
al studies indicate that many MMT
clients increase their cocaine or crack
use during treatment, often in their 
desire to counter the undesirable 
(e. g., depressive) effects of methadone
through the stimulating effects of co-
caine or crack (Fischer et al., 2005b;
Hunt et al., 1984; Best et al., 2000). 
Needle exchange programs (NEPs)
are widely available in Canada, aiming
to reduce unsafe injecting practices.
Also influenced by increased cocaine-
injecting, many programs have begun
to implement more generous distribu-
tion and lower-threshold practices
(Strathdee et al., 1997b; Federal/
Provincial/Territorial Committee on
Injection Drug Use, 2001; Hankins,
1998). NEPs are now complemented
by an experimental Supervised Injec-
tion Facility (SIF) in Vancouver, with
the goal of reducing mortality and
morbidity among injectors (Kerr, Tyn-
dall, Li, Montaner, & Wood, 2005).
Interventions targeting crack users
specifically had been fully absent until
very recently. Over the past couple of
years, community-based initiatives in
some Canadian cities have begun to dis-
tribute so-called »safer crack use kits«,
providing crack users with safer use ma-
terials as well as providing service refer-
rals (Haydon et al., 2005a). The »crack
kit« initiatives are rather controversial,
un-evaluated and receive little to no
public (funding) support to date. Advo-
cates have called for the Vancouver SIF
– akin to European models – to add a
»safer inhalation« room to the facility,
yet such proposals to date have been
rejected (Haydon et al., 2005b). 
Methods
The OPICAN cohort is one compo-
nent of a larger research program on
»Illicit Opiate Addiction Research,
Treatment and Policy«, the purpose of
which is to monitor key social, health
and drug use characteristics of illicit
opioid and other drug users across
Canada in the five cities of Vancouver,
Edmonton, Toronto, Montreal and
Quebec City. The cohort baseline (N =
677) recruited participants by commu-
nity- and outreach-based snowball
methods between March and Decem-
ber 2002 who at recruitment a) used il-
licit opioids regularly and b) were not
in any form of treatment in the past six
months (see Fischer et al., 2005, for
details of study methodology). Study
applicants underwent a (toll-free) tele-
phone screener; if eligible, subjects
provided informed consent, and were
offered service referrals if required. The
uniform study protocol across sites
consisted of an interviewer-adminis-
tered questionnaire on social, health,
and drug use items, oral fluid im-
munoassay screen for infectious dis-
ease antibodies (HIV, hepatitis C, hep-
atitis B), and short standardized psy-
chiatric assessments. Data were col-
lected anonymously; subjects received
$20 compensation for baseline assess-
ment, and have been followed up sub-
sequently. The study received ethics ap-
proval (REB) in all participating study
sites (Fischer et al., 2005a).
Descriptive analyses (i.e., prevalence
of drugs used in sample and by city)
were conducted for the baseline sam-
ple. For the purpose of analyzing dif-
ferences of selected factors between co-
caine or crack involved cohort partici-
pants respectively, the following sub-
samples were selected: a) those who
reported cocaine use (but no crack) in
the last 30 days (n = 171); b) those who
reported crack use (but no cocaine) in
the last 30 days (n = 175) in addition to
their opioid use. Subjects reporting the
use of both cocaine and crack were not
included in the present analysis in order
to test for differences of a number of fac-
tors between the two selected drug
combination groups, included in the
analyses as a dichotomous variable
(coded 0 for crack co-users only and 1
for cocaine co-users only). Bivariate
tests for significant differences were as-
sessed by means of cross-tabulations
(chi-square statistic) and mean com-
parisons (t-test statistic). 
Results
The OPICAN study sample was
characterized by a high degree of poly-
drug use. In terms of opioid use, about
two thirds of the sample reported hero-
in use, although sizable minorities re-
ported the use of other opioids (e. g.,
Dilaudid, Tylenol 3 or 4, street metha-
done). About half the study sample also
reported the use of cocaine or crack
(each 55%). In addition, both the use
of alcohol and the use of benzo-
diazepines were reported by a sizable
proportion of the study population.
Fischer et al. | Cocaine and Crack Use Among Canadian Opiate Users
Drug Used Percent (and no.)
Alcohol 64.4% (436)
Cocaine 54.7% (370)
Crack 54.8% (371)
Demerol 4.6% (31)
Dilaudid 33.1% (224)
Heroin 67.2% (455)
Methadone (from street) 21.3% (144)
Tylenol 3 or 4 32.5% (220)
Valium 36.2% (245)
Table 1: Drug use prevalence (last
30 days) in the OPICAN baseline
sample (N = 677)
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As already demonstrated elsewhere
(Fischer et al., 2005a), both the use of
the various opioids as well as cocaine
and crack differed substantially be-
tween study sites (table 2). While the
use of heroin, for example, varied con-
siderably across the cities, similarly
stark local differences were evident for
cocaine and crack use. Cocaine use was
highly prevalent in the two Quebec sites
(Quebec City and Montreal), yet only
reported by a sample minority in the
cities of Vancouver, Toronto and Ed-
monton. For crack use, the prevalence
distribution was the opposite, with high
prevalence in the three anglophone
cities, and low prevalence in Montreal
and Quebec City.
In terms of route of administration of
cocaine and crack in the OPICAN
sample, about three in four users
(75.2%) reported cocaine use by inject-
ing (no table shown). As also shown
elsewhere, cocaine injection in a large
number of instances occurs in combi-
nation with other drugs (typically opi-
oids, i. e., so-called injected »speed-
ball«; Fischer et al., 2005a). The vast
majority (87.2%) of those who also
used crack used the drug by inhaled
(smoked) route of administration. 
When comparing cocaine and crack
co-using sub-populations of illicit opi-
oid users in OPICAN, key differences
were observed when comparing the
two groups on specific indicators. On
socio-economic indicators (table 3),
the cocaine co-users featured a signifi-
cantly higher proportion of persons
who were permanently housed and
who reported some form of paid work
or legal income (paid work (legal) was
marginally significant (see table 3 for
details)). Conversely, the crack co-user
sub-population reported larger pro-
portions of persons who generated in-
come through drug dealing or sex work
(sex work was marginally significant
(see table 3 for details)). However, in
both groups about the same propor-
tion received some form of social sup-
port income. The crack co-user group
furthermore reported a much larger
prevalence of cases who had been ar-
rested for criminal activity or been to
detention within the past year. While
the crack user group was somewhat
older on average compared to the co-
caine group, no difference was found
regarding the distribution of gender. 
On key health risk or status charac-
teristics (table 4), crack co-users indi-
cated a higher degree of physical
health problems over the cocaine co-
user group; conversely, the cocaine
sub-sample reported almost double the
prevalence of depressive symptoms 
(as measured by CIDI-SF). While this
group reported a significantly higher
current proportion of drug injectors,
this difference did not hold for lifetime
prevalence of injecting between the
two groups. There were also no signifi-
cant differences in HIV or HCV (anti-
body) status between the two groups.
Discussion
In the above, we have explored
differences in socio-economic and
health-related indicators between two
sub-samples of co-substance using
participants in a Canadian multi-city
cohort of illicit opioid users, namely 1)
those who reported co-use of cocaine
(but exclusive of crack), and 2) those
who reported co-use of crack (but ex-
clusive of cocaine) in addition to their
opioid (and other) drug use. The main
purpose of these analyses has been to
tentatively investigate potential differ-
ences between those two sub-popula-
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Edmonton Montreal Quebec-City Toronto Vancouver 
Drug Used (n=93) (n=157) (n=87) (n=139) (n=201)
Heroin 28.0%(26) 89.8%(141) 36.8%(32) 52.5%(73) 91.0%(183)
Cocaine 35.5%(33) 68.8%(108) 79.3%(69) 46.0%(64) 47.8%(96)
Crack 66.7%(62) 28.0%(44) 3.4%(3) 63.3%(88) 86.6%(174)
Table 2: Heroin, cocaine and crack use prevalence in the last 30 days in the
OPICAN baseline sample, by site (N = 677) 
Socio-economic and crack users only cocaine users only ChiSquare
demographic indicators (n=175) (n=171) (df=1) Sig.
Permanent housing 34.9% (61) 57.3% (98) 17.56 0.000
Paid work (legal) income (last 30 days) 14.3% (25) 22.2% (38) 3.66 0.056
Social Assistance/Welfare/Disability 
income (last 30 days) 68.6% (120) 68.4% (117) 0.00 0.976
Sex work/hustling income (last 30 days) 26.3% (46) 18.1% (31) 3.33 0.068
Drug dealing income (last 30 days) 38.9% (68) 9.4% (16) 40.94 0.000
Other criminal income (last 30 days) 15.4% (27) 11.7% (20) 1.03 0.311
Arrested (past 12 months) 57.1% (100) 40.9% (70) 9.09 0.003
Detention (past 12 months) 48.6% (85) 32.2% (55) 9.67 0.002
Gender (% Male) 62.9% (110) 69.6% (119) 1.75 0.186
Age, mean 36.2  (SD=9.1) 33.3  (SD=9.1) 2.94 0.004
(T-value)
Table 3: Associations between socio-economic and demographic indicators
and crack and cocaine co-use in OPICAN baseline sample (n = 346).
Health-related indicators crack users only cocaine users only ChiSquare
(n=175) (n=171) (df=1) Sig.
Physical health problems 72.0% (126) 61.4% (105) 4.38 0.036
Depression 34.3% (60) 62.0% (106) 17.59 0.000
Injection drug use (lifetime) 89.1% (156) 93.0% (159) 1.56 0.211
Injection drug use (past 30 days) 70.3% (123) 83.0% (142) 7.85 0.005
Overdose (past 6 months) 10.9% (19) 17.0% (29) 2.70 0.101
Drug Treatment (past 12 months) 26.3% (46) 31.0% (53) 0.94 0.333
HIV (n=298) 11.9% (16) 17.8% (29) 2.03 0.154
HCV (n=275) 57.1% (72) 51.7% (77) 0.82 0.365
Table 4: Associations between health-related indicators and crack and
cocaine co-use in OPICAN baseline sample (n = 346).
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tions, also as a basis for suggestions for
further inquiries as well as implications
for interventions. 
First, our overall observations with
regards to cocaine and crack co-use
within the OPICAN cohort demon-
strated that the prevalence of the co-
use of these drugs among illicit opioid
users differed considerably between
our five study sites. This points to the
fact that the co-use of these substances
is likely anchored within a wider social
ecology of local drug cultures and mar-
kets that need to be understood for sys-
tematic causal analyses (Bourgois,
1995; Kemmesies, 1997; Kerr et al.,
2005), also implying that one may have
to limit assumptions of free »choice« by
consumers resulting in the substance
use patterns observed. On first glance,
it is quite striking that cocaine co-use is
so disproportionately more prevalent
in Montreal and Quebec City than in
the other sites. This may point to local-
ly stratified or determined drug cul-
tures, yet we can neither meaningfully
speculate nor offer empirical explana-
tions on this issue of site influences; this
needs to be a theme of future analyses.
What these data demonstrate, how-
ever, is that drug use profiles are local-
ly distinct; this also generally implies
that interventions – be it prevention or
treatment – need to be shaped and in-
formed on the basis of local needs, di-
rectly responding to the concretely ex-
isting circumstances. 
We also note that the co-use of co-
caine and crack within the OPICAN
cohort forms part of a rather diverse
picture of poly-drug use, predominant-
ly characterized by the use of various
opioids, crack and/or cocaine, but also
other substances, including benzo-
diazepines, alcohol and cannabis. Our
present analysis did not include any
focus on the association of different
drug types due to space limitations.
However, a separate analysis in OPI-
CAN exploring possibly distinct clus-
ters of drugs used (by »latent class
analysis«) suggested that the observed
phenomena of (oral) crack and (inject-
ed) cocaine use may indeed be associ-
ated with different drug user typolo-
gies; namely, (oral) crack use was pre-
dominantly associated with non-in-
jected (smoked) heroin use, and (in-
jected) cocaine use was predominantly
associated with injected heroin use
(Monga et al., 2005). Even a careful in-
terpretation of these data thus seems to
suggest that the use of specific drugs
(and specific forms of administration)
cannot fully be understood in isola-
tion, yet requires exploration in the in-
teractive context of other drugs used
(see also Leri et al., 2003).
When looking at the two sub-sam-
ples under examination, we have de-
tected several preliminary indicators
of differences associated with the phe-
nomena of cocaine versus crack co-
use. The first striking difference is that
on more or less all the indicators of so-
cial deviance or marginalization (i.e.,
non-permanent housing, illegal in-
come, arrests and detention), the po-
pulation of crack co-users sets itself
negatively apart from the cocaine co-
users. These exploratory findings ap-
pear to support the variedly illustrated
hypothesis that crack users – specifi-
cally in contemporary North Ameri-
can contexts – constitute a distinct
sub-group of extremely marginalized
and socially dis-integrated street drug
users, thus a population of the »mar-
ginalized among the marginalized«
(Haydon et al., 2005b; Williams, 1992).
This status is, among other ways, ex-
pressed through the fact that crack
users in many instances appear to lack
even the most basic qualities of social
stability or support, and are highly in-
volved in criminal activity, including
sex work (Inciardi et al., 2001; Bourgo-
is & Dunlap, 1993). While these char-
acteristics are interesting from a sub-
cultural studies point of view, they are
equally relevant for public health or in-
terventions: It has been demonstrated
that social marginalization can be
strongly associated with various key
forms of drug use related harms, for ex-
ample, infectious disease transmission
risks, (fatal and non-fatal) overdose,
health care access and utilization, etc.
(Patrick et al., 2001; Palepu et al., 1999;
Fischer et al., 2004a; O’Driscoll et al.,
2001). These insights pose challenges
for interventions, in that approaches
that focus on the use of crack alone
may be too narrow or insufficient.
Rather, targeted interventions for
crack use may require, as one priority,
measures that aim to reduce the ex-
treme degree of marginalization (in-
cluding criminal involvement, sex
work, homelessness, etc.) among crack
users. One main benefit of »safer crack
kit« initiatives may thus be their func-
tion as a »contact vehicle« for service
providers to connect with crack users,
and link them with social and health
service programs (Haydon et al.,
2005a). It seems inevitable that such
anti-marginalization efforts become
integral components of crack use inter-
ventions, especially in cities where
crack use is highly prevalent.
Given that the phenomenon of co-
caine co-use observed in the OPICAN
cohort occurred predominantly by in-
jection while crack was used predomi-
nantly in oral (smoked) form, it is fur-
ther interesting to note that the (exclu-
sive) co-involvement with one or the
other substance further delineated dif-
ferences between the two groups in
terms of overall current routes of drug
(beyond cocaine or crack) administra-
tion. In other words, co-users of co-
caine were more likely to be current
drug injectors, whereas co-users of
crack were more likely to be current
drug non-injectors in our study. This
may point to the possibility that drug
use profiles may in fact be strongly in-
fluenced by (cultural) dynamics princi-
pally linked to route of administration
(McBride, Pates, Arnold, & Ball, 2001;
Giddings, Christo, & Davy, 2003), an
issue that calls for further systematic
investigation as this may also have
high relevance for secondary preven-
tion specifically considering injection
risks and behaviors. At the same time,
our study samples indicated no differ-
ences between the two analysis groups
in terms of lifetime injection history,
suggesting that these behavioral differ-
ences may be in flux and contingent on
temporary and/or local influences
(bearing more relevance for preven-
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tion). This may explain the fact that the
two sub-samples indicated no differ-
ences in HIV or HCV status, although
evidence suggests that oral crack use
may pose an independent risk factor
for HCV infection status within popu-
lations of IDUs (Thorpe et al., 2000;
Tortu et al., 2004).
One detail standing out is the stark-
ly higher prevalence of depressive
symptoms among the cocaine co-user
group. While the disproportionately
elevated level of mental health prob-
lem symptoms among illicit substance
users is well documented (Krausz,
Degkwitz, Kuhne, & Verthein, 1998;
Frei & Rehm, 2002), it is not immedi-
ately evident why such pronounced dif-
ferences in depression symptoms were
observed between the cocaine and
crack co-user groups. One possible ex-
planation – following Khantzian’s self-
medication hypothesis (Khantzian,
1997; Krausz et al., 1998) – may be that
cocaine specifically may be a more ef-
fective and thus more desired drug use
response to the experience of depres-
sion symptoms among users. While
these interaction dynamics require fur-
ther inquiry, the above observations
have important implications for inter-
ventions. It seems imperative that tar-
geted interventions for this group re-
spond to these specific circumstances
and needs of co-morbid cocaine co-
users. While true co-morbidity inter-
ventions at this point are mostly limit-
ed to scarce (institutional) co-morbidi-
ty treatment programs (Charney, Para-
herakis, & Gill, 2001; Brady & Malcolm,
2004), there seems to be a substantive
need to think about the implementa-
tion low-threshold frontline or out-
reach (»harm reduction«) interven-
tions aiming at the co-occurrence of
drug use and depression in considera-
tion of this group of co-morbid cocaine
co-users, especially since cocaine co-
users also displayed an elevated level of
injection risks. Such interventions may
utilize both models of brief assessments
and interventions used for depression
in other areas.
As stated above, the present study
has been exploratory, and has some key
limitations. First, our sub-populations
examined for the purpose of this analy-
sis were selective – albeit empirical –
»ideal-types« of drug user groups with-
in the larger OPICAN cohort. In other
words, we limited our explorative
analysis to the »pure« co-users of co-
caine versus crack, while a substantial
number of OPICAN subjects were
users of none or both (yet not consid-
ered in our analyses). Our analyses
have also been limited to a select cata-
logue of variables, explored by bi-vari-
ate analysis. However, this approach
was justified by the exploratory purpose
and nature of this paper, which should
be continued elsewhere by appropriate
methods (e. g., multi-variate analysis).
Furthermore, most of the data used in
our analyses has been based on self-re-
port (including sensitive issues, i.e. sex
work, criminal activity), though studies
have shown the high validity of such
data obtained from illicit drug user sam-
ples (Harrison, 1995). 
Overall, we have illustrated that
both crack and cocaine co-use are pri-
mary components of the diversified
poly-drug use realities involving opi-
oids and other drugs within street drug
use populations in North America (see
also Fischer et al., 2000a). Our study
has provided preliminary evidence
that co-users of cocaine and crack may
be part of rather distinct groups, as de-
scribed by key characteristics and out-
comes relevant for public health; given
these tentative correlations, more sys-
tematic investigation of these differ-
ences and the causal factors behind
them – especially focussing on the pro-
cesses of choice of drugs, the role of
drug cultures and the link between de-
pression and cocaine use – are called
for as they may offer crucial evidence
for targeted interventions.
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